rs35592567

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003722.5(TP63):​c.*2345C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.204 in 213,336 control chromosomes in the GnomAD database, including 4,473 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.21 ( 3214 hom., cov: 32)
Exomes 𝑓: 0.20 ( 1259 hom. )

Consequence

TP63
NM_003722.5 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.617

Publications

18 publications found
Variant links:
Genes affected
TP63 (HGNC:15979): (tumor protein p63) This gene encodes a member of the p53 family of transcription factors. The functional domains of p53 family proteins include an N-terminal transactivation domain, a central DNA-binding domain and an oligomerization domain. Alternative splicing of this gene and the use of alternative promoters results in multiple transcript variants encoding different isoforms that vary in their functional properties. These isoforms function during skin development and maintenance, adult stem/progenitor cell regulation, heart development and premature aging. Some isoforms have been found to protect the germline by eliminating oocytes or testicular germ cells that have suffered DNA damage. Mutations in this gene are associated with ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3); split-hand/foot malformation 4 (SHFM4); ankyloblepharon-ectodermal defects-cleft lip/palate; ADULT syndrome (acro-dermato-ungual-lacrimal-tooth); limb-mammary syndrome; Rap-Hodgkin syndrome (RHS); and orofacial cleft 8. [provided by RefSeq, Aug 2016]
TP63 Gene-Disease associations (from GenCC):
  • ADULT syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • ankyloblepharon-ectodermal defects-cleft lip/palate syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • limb-mammary syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • Rapp-Hodgkin syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • premature ovarian failure 21
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • TP63-related ectodermal dysplasia spectrum with limb and orofacial malformations
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • split hand-foot malformation 4
    Inheritance: AD Classification: MODERATE Submitted by: Illumina
  • EEC syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • split hand-foot malformation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 3-189896847-C-T is Benign according to our data. Variant chr3-189896847-C-T is described in ClinVar as Benign. ClinVar VariationId is 344431.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.208 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003722.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TP63
NM_003722.5
MANE Select
c.*2345C>T
3_prime_UTR
Exon 14 of 14NP_003713.3
TP63
NM_001114980.2
MANE Plus Clinical
c.*2345C>T
3_prime_UTR
Exon 12 of 12NP_001108452.1Q9H3D4-2
TP63
NM_001329964.2
c.*2345C>T
3_prime_UTR
Exon 14 of 14NP_001316893.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TP63
ENST00000264731.8
TSL:1 MANE Select
c.*2345C>T
3_prime_UTR
Exon 14 of 14ENSP00000264731.3Q9H3D4-1
TP63
ENST00000354600.10
TSL:1 MANE Plus Clinical
c.*2345C>T
3_prime_UTR
Exon 12 of 12ENSP00000346614.5Q9H3D4-2

Frequencies

GnomAD3 genomes
AF:
0.206
AC:
31242
AN:
151968
Hom.:
3215
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.206
Gnomad AMI
AF:
0.245
Gnomad AMR
AF:
0.162
Gnomad ASJ
AF:
0.173
Gnomad EAS
AF:
0.166
Gnomad SAS
AF:
0.219
Gnomad FIN
AF:
0.258
Gnomad MID
AF:
0.278
Gnomad NFE
AF:
0.210
Gnomad OTH
AF:
0.211
GnomAD4 exome
AF:
0.201
AC:
12289
AN:
61250
Hom.:
1259
Cov.:
0
AF XY:
0.203
AC XY:
5797
AN XY:
28572
show subpopulations
African (AFR)
AF:
0.207
AC:
568
AN:
2738
American (AMR)
AF:
0.153
AC:
278
AN:
1822
Ashkenazi Jewish (ASJ)
AF:
0.184
AC:
711
AN:
3874
East Asian (EAS)
AF:
0.155
AC:
1384
AN:
8950
South Asian (SAS)
AF:
0.225
AC:
118
AN:
524
European-Finnish (FIN)
AF:
0.252
AC:
116
AN:
460
Middle Eastern (MID)
AF:
0.240
AC:
94
AN:
392
European-Non Finnish (NFE)
AF:
0.212
AC:
7926
AN:
37402
Other (OTH)
AF:
0.215
AC:
1094
AN:
5088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
504
1008
1513
2017
2521
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.205
AC:
31238
AN:
152086
Hom.:
3214
Cov.:
32
AF XY:
0.206
AC XY:
15311
AN XY:
74332
show subpopulations
African (AFR)
AF:
0.206
AC:
8531
AN:
41488
American (AMR)
AF:
0.162
AC:
2478
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.173
AC:
598
AN:
3466
East Asian (EAS)
AF:
0.166
AC:
855
AN:
5160
South Asian (SAS)
AF:
0.219
AC:
1060
AN:
4830
European-Finnish (FIN)
AF:
0.258
AC:
2726
AN:
10548
Middle Eastern (MID)
AF:
0.269
AC:
79
AN:
294
European-Non Finnish (NFE)
AF:
0.210
AC:
14247
AN:
67994
Other (OTH)
AF:
0.208
AC:
441
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1281
2562
3844
5125
6406
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
338
676
1014
1352
1690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.207
Hom.:
711
Bravo
AF:
0.198
Asia WGS
AF:
0.174
AC:
602
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
1
Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3 (1)
-
-
1
Orofacial cleft 8 (1)
-
-
1
TP63-Related Spectrum Disorders (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
9.2
DANN
Benign
0.51
PhyloP100
0.62
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35592567; hg19: chr3-189614636; COSMIC: COSV53216247; COSMIC: COSV53216247; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.